We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

137 hedge funds and large institutions have $1.12B invested in Abiomed Inc in 2014 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

51% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 37

9% more funds holding

Funds holding: 126137 (+11)

7% more capital invested

Capital invested by funds: $1.05B → $1.12B (+$75.9M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

42% less call options, than puts

Call options by funds: $686K | Put options by funds: $1.18M

Holders
137
Holders Change
+11
Holders Change %
+8.73%
% of All Funds
3.96%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
25
Increased
56
Reduced
37
Closed
12
Calls
$686K
Puts
$1.18M
Net Calls
-$493K
Net Calls Change
+$3.95M
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$7.79M +$720K +26,043 +10%
Public Employees Retirement Association of Colorado
27
Public Employees Retirement Association of Colorado
Colorado
$6.72M +$6.78M +245,000 +1,872%
Principal Financial Group
28
Principal Financial Group
Iowa
$5.91M +$271K +9,793 +5%
TCIM
29
TIAA CREF Investment Management
New York
$5.17M -$75.2K -2,720 -1%
Barclays
30
Barclays
United Kingdom
$5.15M +$1.09M +39,530 +25%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$5.09M -$25.3K -914 -0.4%
PCM
32
Portolan Capital Management
Massachusetts
$5.07M -$338K -12,208 -6%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$5.06M +$405K +14,625 +8%
STC
34
SEI Trust Company
Pennsylvania
$4.83M
PRCM
35
Pine River Capital Management
Minnesota
$4.66M +$3.03M +109,582 +158%
CCM
36
Cupps Capital Management
Illinois
$4.58M -$2.09M -75,641 -30%
MOACM
37
Mutual of America Capital Management
New York
$4.36M
RFC
38
Russell Frank Company
Washington
$4.18M +$713K +25,777 +18%
CS
39
Credit Suisse
Switzerland
$4.12M +$179K +6,481 +4%
Ameriprise
40
Ameriprise
Minnesota
$3.71M +$103K +3,715 +3%
BIM
41
BlackRock Investment Management
Delaware
$3.29M +$28.2K +1,018 +0.8%
ACM
42
Apex Capital Management
Ohio
$3.27M +$454K +16,418 +15%
DIA
43
Denver Investment Advisors
Colorado
$3.21M +$706K +25,512 +26%
Thrivent Financial for Lutherans
44
Thrivent Financial for Lutherans
Minnesota
$3.16M +$3M +108,600 +848%
VAM
45
Visium Asset Management
New York
$3.05M +$3.24M +117,279 New
Charles Schwab
46
Charles Schwab
California
$2.68M +$190K +6,877 +7%
Invesco
47
Invesco
Georgia
$2.47M +$209K +7,568 +9%
RPAM
48
Rhenman & Partners Asset Management
Sweden
$2.34M +$689K +24,916 +38%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$2.19M +$27.7K +1,000 +1%
Goldman Sachs
50
Goldman Sachs
New York
$2.14M -$413K -14,922 -15%

ABMD Hedge Fund Activity: Q1 2014 in Review

137 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2014, worth a combined $1.12B — up 7.3% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ABMD positions and 12 closed out — a net gain of 13 holders — while 56 added to existing stakes and 37 trimmed.

The largest buyer was Assured Investment Management, opening a new position worth an estimated $44.5M. The largest seller was Palo Alto Investors, cutting an estimated $13.4M.

  • 137 institutional investors held Abiomed Inc (ABMD) as of Q1 2014, up from 126 in Q4 2013.
  • Funds reported $1.12B of Abiomed Inc stock for Q1 2014, up 7.3% quarter-over-quarter.
  • 25 funds opened new Abiomed Inc positions in Q1 2014 and 12 closed out, a net change of +13 holders.
  • The largest Abiomed Inc buyer in Q1 2014 was Assured Investment Management, an estimated $44.5M added.
  • The largest Abiomed Inc seller in Q1 2014 was Palo Alto Investors, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2014.